e-learning
resources
Madrid 2019
Monday, 30.09.2019
FeNO in airway diseases and asthma-COPD overlap identification
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cost analysis for therapy management of asthmatics with FeNO in primary care in Germany
S. Wiener (Stuttgart, Germany), T. Wollensak (Stuttgart, Germany), S. Wegner (Waiblingen, Germany), C. Ernst (Stuttgart, Germany)
Source:
International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Session:
FeNO in airway diseases and asthma-COPD overlap identification
Session type:
Thematic Poster
Number:
2626
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Wiener (Stuttgart, Germany), T. Wollensak (Stuttgart, Germany), S. Wegner (Waiblingen, Germany), C. Ernst (Stuttgart, Germany). Cost analysis for therapy management of asthmatics with FeNO in primary care in Germany. 2626
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cost analysis of FeNO for asthma diagnosis in primary care in Germany.
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018
Inhaler treatment prescription in adults in a primary care setting
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Feasibility and acceptability of spirometry and FeNO testing in children treated for asthma in primary care
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017
Cost of asthma exacerbations managed in primary care in Spain
Source: Eur Respir J 2001; 18: Suppl. 33, 329s
Year: 2001
FeNO testing for asthma diagnosis in primary care
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Assessment and therapy for COPD patients in real-life primary care
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Spirometry, FeNO, and asthma control in children managed for asthma in primary care
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019
Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Cost and effectiveness of integrated care intervention on the patients with COPD
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
How are we managing our asthmatic patients? Asthma diagnosis and treatment in an urban primary care practice
Source: Eur Respir J 2004; 24: Suppl. 48, 85s
Year: 2004
Economic implications of treatment pathways of asthma exacerbations managed in primary care in Spain
Source: Eur Respir J 2001; 18: Suppl. 33, 235s
Year: 2001
SABA and ICS use among mild asthma patients in UK primary care
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Evaluation of COPD treatment success by office-based pneumologists in Germany using the example of tiotropium
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
Source: ERJ Open Res, 8 (1) 00606-2021; 10.1183/23120541.00606-2021
Year: 2022
Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
Monitoring of asthma control in primary care
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept